Israel - heprea - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride - glutamic acid hydrochloride - dipeptiven is indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen.in patients in extreme cases of hypercatabolic stage such as major abdominal surgery, bmt, diffuse injury of gi mucous.

Israel - heprea - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

Israel - heprea - Ministry of Health

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

Israel - heprea - Ministry of Health

megapharm ltd - pilocarpine hydrochloride - טבליה - pilocarpine hydrochloride 5 mg - pilocarpine - pilocarpine - for the treatment of symptoms of xerostomia and salivary gland hypofunction caused by radiotherapy for cancer of the head and neck. sjogren detected by biopsy.

Israel - heprea - Ministry of Health

megapharm ltd - hydrocortisone acetate; pramocaine hydrochloride - קצף - pramocaine hydrochloride 0.9363 %w/w; hydrocortisone acetate 0.9363 %w/w - relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Israel - heprea - Ministry of Health

sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.

Israel - heprea - Ministry of Health

megapharm ltd - hydrocortisone acetate; pramocaine hydrochloride - קצף - hydrocortisone acetate 1 %; pramocaine hydrochloride 1 % - hydrocortisone

Israel - heprea - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 5000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

Israel - heprea - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 10000 iu / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with chemotherapy. treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency* and are receiving anti-tumor therapy. * deficiency is defined as an

Israel - heprea - Ministry of Health

roche pharmaceuticals (israel) ltd - epoetin beta - תמיסה להזרקה - epoetin beta 4000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative